RY 170.3 -0.8096% SHOP 145.34 -0.4452% TD 78.23 0.3206% ENB 59.82 -0.2168% BN 78.84 -0.5801% TRI 224.58 0.0445% CNQ 47.21 0.3614% CP 102.88 -0.1843% CNR 149.43 0.2348% BMO 131.48 0.0533% BNS 78.71 0.421% CSU 4503.0698 1.5097% CM 90.72 0.9683% MFC 45.03 -1.0547% ATD 77.2 -0.5026% NGT 60.11 -0.2489% TRP 68.79 -1.1638% SU 57.1 -0.1923% WCN 260.8 -0.401% L 177.26 1.1758%

Andlauer Healthcare Gr

Industrials CA AND

42.77CAD
0.62(1.47%)

Last update at 2024-11-20T21:00:00Z

Day Range

41.9542.77
LowHigh

52 Week Range

36.2344.92
LowHigh

Fundamentals

  • Previous Close 42.15
  • Market Cap1689.56M
  • Volume7095
  • P/E Ratio27.22
  • Dividend Yield0.93%
  • EBITDA110.66M
  • Revenue TTM651.25M
  • Revenue Per Share TTM15.93
  • Gross Profit TTM 223.30M
  • Diluted EPS TTM1.58

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 103.76M 108.44M 46.58M 42.35M 38.72M
Minority interest - - 0.00000M -0.57200M 5.92M
Net income 76.28M 89.95M 37.71M 29.77M 26.72M
Selling general administrative 48.50M 37.05M 28.61M 23.09M 21.68M
Selling and marketing expenses - - - - -
Gross profit 158.85M 110.75M 79.55M 68.08M 62.55M
Reconciled depreciation 64.45M 42.72M 28.02M 25.71M 23.49M
Ebit 110.34M 73.70M 50.94M 44.99M 40.30M
Ebitda 175.07M 119.45M 79.20M 71.56M 63.79M
Depreciation and amortization 64.72M 45.75M 28.26M 26.57M 23.49M
Non operating income net other - - - - -
Operating income 110.34M 73.70M 50.94M 44.99M 40.87M
Other operating expenses 538.08M 366.41M 263.40M 245.00M 236.14M
Interest expense 6.86M 6.22M 4.59M 3.50M 3.05M
Tax provision 27.48M 18.49M 8.87M 12.00M 10.53M
Interest income 6.26M 34.37M 4.31M 2.50M 2.17M
Net interest income -6.25900M -6.02100M -4.31000M -2.49900M -2.16900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 27.48M 18.49M 8.87M 12.00M 10.53M
Total revenue 648.42M 440.12M 314.34M 289.99M 277.01M
Total operating expenses 48.50M 37.05M 28.61M 23.09M 21.68M
Cost of revenue 489.58M 329.36M 234.79M 221.90M 214.46M
Total other income expense net -6.58700M 34.74M -4.35900M -2.64400M -2.15000M
Discontinued operations - - - - -
Net income from continuing ops 76.28M 89.95M 37.71M 30.34M 28.18M
Net income applicable to common shares 76.28M 89.95M 37.71M 29.77M 26.72M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 682.43M 712.46M 644.17M 252.80M 213.00M
Intangible assets 144.36M 164.79M 158.46M 8.61M 1.70M
Earning assets - - - - -
Other current assets 6.61M 4.42M 4.66M 2.83M 2.31M
Total liab 212.86M 271.47M 292.05M 158.47M 151.49M
Total stockholder equity 469.57M 440.99M 352.12M 94.33M 61.51M
Deferred long term liab - - - - -
Other current liab 0.45M 16.31M 13.68M 3.03M 17.39M
Common stock 718.79M 727.84M 719.94M 549.66M 549.68M
Capital stock 718.79M 727.84M 719.94M 549.66M 549.68M
Retained earnings -269.72200M 176.62M 111.23M 29.13M -0.65200M
Other liab - 48.95M 51.72M 1.98M 0.66M
Good will 190.56M 192.91M 176.74M 25.87M 19.72M
Other assets - 5.81M 8.68M 6.95M 0.98M
Cash 59.74M 65.86M 24.99M 30.15M 18.71M
Cash and equivalents - 65.86M 24.99M 30.15M -
Total current liabilities 69.49M 85.78M 90.53M 48.08M 56.70M
Current deferred revenue 0.97M 1.14M 1.82M 1.04M 0.88M
Net debt 68.16M 97.43M 162.26M 99.47M 98.48M
Short term debt 27.70M 26.55M 37.45M 21.20M 23.06M
Short long term debt - - 11.00M - 3.93M
Short long term debt total 127.90M 163.29M 187.25M 129.61M 117.20M
Other stockholder equity 6.31M 5.81M 4.97M 4.45M 1.39M
Property plant equipment - 175.88M 178.11M 118.92M 103.33M
Total current assets 175.11M 172.08M 122.18M 92.45M 87.26M
Long term investments - - - - -
Net tangible assets - 83.29M 16.92M 59.85M 40.08M
Short term investments - - - - 0.00000M
Net receivables 103.44M 98.48M 90.20M 58.25M 65.17M
Long term debt 24.82M 49.56M 49.29M 24.67M 24.55M
Inventory 5.33M 3.33M 2.33M 1.23M 1.07M
Accounts payable 40.38M 41.78M 37.59M 24.32M 24.06M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 14.19M -469.27400M -484.01700M -488.91600M -488.91600M
Additional paid in capital - - - - -
Common stock total equity - - - 549.66M 549.68M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.91M 1.00M 0.85M 0.81M 0.94M
Deferred long term asset charges - - - - -
Non current assets total 507.31M 540.38M 521.99M 160.34M 125.73M
Capital lease obligations 103.08M 113.73M 126.96M 104.95M 88.71M
Long term debt total - 136.74M 149.81M 108.42M 94.14M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -45.55700M -7.64800M -20.37100M -6.16500M -2.49700M
Change to liabilities 1.49M 4.45M -0.94800M -2.15400M 4.13M
Total cashflows from investing activities -45.55700M -183.38200M -20.37100M -6.16500M -2.49700M
Net borrowings -40.03400M 10.89M -24.66500M -176.35700M -16.81700M
Total cash from financing activities -51.58700M 93.89M -19.19600M -89.78100M -46.33200M
Change to operating activities 0.33M -0.12100M -0.26900M -1.07900M 0.17M
Net income 76.28M 89.95M 37.71M 30.34M 28.18M
Change in cash 40.87M -5.15800M 11.44M -34.94500M 3.51M
Begin period cash flow 24.99M 30.15M 18.71M 53.66M 50.15M
End period cash flow 65.86M 24.99M 30.15M 18.71M 53.66M
Total cash from operating activities 137.13M 84.09M 51.00M 61.00M 52.34M
Issuance of capital stock 0.00000M 97.05M 0.00000M 172.50M -
Depreciation 64.45M 42.72M 28.02M 25.71M 23.49M
Other cashflows from investing activities -17.59700M -173.71400M -14.93200M 0.00000M 0.09M
Dividends paid 10.88M 7.85M 7.93M 112.02M 26.00M
Change to inventory -0.31700M -0.47200M -0.15700M 0.29M -0.20400M
Change to account receivables -2.85500M -14.18400M -3.04000M -2.63000M -3.44700M
Sale purchase of stock 0.00000M 97.05M 0.00000M 50.00M -
Other cashflows from financing activities 11.33M 68.80M 13.40M 76.09M -3.51500M
Change to netincome -0.79200M -42.56900M -3.13800M 2.44M 1.46M
Capital expenditures 27.96M 9.67M 5.44M 6.17M 2.59M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -3.07600M -6.25200M -11.59500M 3.09M 0.66M
Stock based compensation 1.30M 1.86M 3.04M 1.39M -
Other non cash items 0.22M -40.39300M 0.10M 0.21M 0.00100M
Free cash flow 109.17M 74.42M 45.56M 54.84M 49.75M

Peer Comparison

Sector: Industrials Industry: Integrated Freight & Logistics

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AND
Andlauer Healthcare Gr
0.62 1.47% 42.77 27.22 23.75 2.59 4.18 2.78 10.76
CJT
Cargojet Inc
-3.43 2.70% 123.39 600.00 22.12 2.35 3.07 3.10 9.04
TTNM
Titanium Transportation Group Inc.
-0.06 2.36% 2.48 71.33 30.58 0.21 0.93 0.59 5.46

Reports Covered

Stock Research & News

Profile

Andlauer Healthcare Group Inc., a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics. It provides logistics and distribution services, including client and customer integration, transportation and inventory management, distribution and fulfillment, and warehousing solutions; and packaging services, such as co-packing and re-packing, assembly, and custom work services, as well as design, supply, and secondary Rx packaging services. The company also offers temperature-controlled services; air freight forwarding services; dedicated and last mile delivery services; and ground transportation services, including less-than-truckload, pick-up and delivery, and courier services, as well as carrier options. It provides services to healthcare manufacturers, wholesalers, distributors, 3PL providers, and others through a platform of technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, blood products, narcotics, precursors, active pharmaceutical ingredients, over-the-counter, cosmetics, health and beauty aids, and medical devices, as well as natural, animal, and consumer health. The company was founded in 1991 and is headquartered in Vaughan, Canada. Andlauer Healthcare Group Inc. operates as a subsidiary of Andlauer Management Group Inc.

Andlauer Healthcare Gr

100 Vaughan Valley Boulevard, Vaughan, ON, Canada, L4H 3C5

Key Executives

Name Title Year Born
Mr. Michael N. Andlauer CEO & Director 1965
Mr. Peter Bromley C.A., CPA CFO & Corp. Sec. 1964
Mr. Charles Robert Brogan Pres of Specialty Solutions 1961
Mr. Stephen Barr Pres of Transportation 1965
Mr. Dean Berg Pres of Logistics NA
Mr. Peter Bromley C.A., CPA CFO & Corporate Secretary 1964
Mr. Charles Robert Brogan President of Specialty Solutions 1961
Mr. Dean Berg President of Logistics NA
Mr. Graham Cromb Chief Strategy Officer NA
Mr. Sandro Caccaro President of Transportation NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.